Retraction
S-Nitroso-L-Cysteine Ameliorated Pulmonary Hypertension in the MCT-Induced Rats through Anti-ROS and Anti-Inflammatory Pathways
Paper Information
Record ID:
62079
Author(s):
Journal:
Publication Date:
January 28, 2021
Retraction Date:
October 11, 2023
(2.1 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9781259Citations (10)
10
Total Citations3
Post-Retraction(30.0%)
5
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
1
Within 30 days
3
Within 1 year
0
After 2+ years
349
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Red-light photons on skin cells and the mechanism of photobiomodulation
M. Herrera, Arthur Pereira Ribas, Paulo Eduardo da Costa et al. (4 authors)
Frontiers in Photonics
Open Access
Published: Sep 2024
2 citations
2 citations
349 days after retraction
Emerging insights into pulmonary hypertension: the potential role of mitochondrial dysfunction and redox homeostasis
Junming Zhang, Huimin Yan, Yan Wang et al. (9 authors)
Molecular and Cellular Biochemistry
Published: Sep 2024
3 citations
3 citations
335 days after retraction
Unleashing the Potential of Nrf2: A Novel Therapeutic Target for Pulmonary Vascular Remodeling
Qin Fang, Yang Bai, Shuiqing Hu et al. (10 authors)
Antioxidants
Open Access
Published: Nov 2023
1 citation
1 citation
27 days after retraction
Retracted: S-Nitroso-L-Cysteine Ameliorated Pulmonary Hypertension in the MCT-Induced Rats through Anti-ROS and Anti-Inflammatory Pathways
Oxidative Medicine And Cellular Longevity
Oxidative Medicine and Cellular Longevity
Open Access
Published: Oct 2023
Same day as retraction
Natural Products for the Treatment of Pulmonary Hypertension: Mechanism, Progress, and Future Opportunities
Zuomei Zeng, Xinyue Wang, Lidan Cui et al. (6 authors)
Current Issues in Molecular Biology
Open Access
Published: Mar 2023
4 citations
4 citations
212 days before retraction
PRDX6-mediated pulmonary artery endothelial cell ferroptosis contributes to monocrotaline-induced pulmonary hypertension
Juan Liao, Shanshan Xie, Yan Deng et al. (7 authors)
Microvascular Research
Open Access
Published: Dec 2022
27 citations
27 citations
292 days before retraction
Important Functions and Molecular Mechanisms of Mitochondrial Redox Signaling in Pulmonary Hypertension
Jorge Reyes-GarcĂa, Abril Carbajal-GarcĂa, Annarita Di Mise et al. (6 authors)
Antioxidants
Open Access
Published: Feb 2022
14 citations
14 citations
590 days before retraction
Endothelial cell ferroptosis mediates monocrotaline-induced pulmonary hypertension in rats by modulating NLRP3 inflammasome activation
Shanshan Xie, Yan Deng, Shenglan Guo et al. (8 authors)
Scientific Reports
Open Access
Published: Feb 2022
104 citations
104 citations
595 days before retraction
Understanding the role of S-nitrosylation/nitrosative stress in inflammation and the role of cellular denitrosylases in inflammation modulation: Implications in health and diseases
Ajanta Chatterji, Debasmita Banerjee, Timothy R. Billiar et al. (4 authors)
Free Radical Biology and Medicine
Published: Jul 2021
23 citations
23 citations
826 days before retraction
Quick Stats
Total Citations:
18
Years Since Retraction:
2.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025